Phase I and Pharmacokinetic Study of Combination Chemotherapy Using Irinotecan and Paclitaxel in Patients with Lung Cancer-Reference-Cited by-同舟云学术

Phase I and Pharmacokinetic Study of Combination Chemotherapy Using Irinotecan and Paclitaxel in Patients with Lung Cancer

Published:2006-03 Issue:3 Volume:1 Page:226-230
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Asai Gyo,Yamamoto Nobuyuki,Kurata Takayasu,Tamura Kenji,Uejima Hisao,Nakagawa Kazuhiko,Fukuoka Masahiro

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference22 articles.

1. Third generation chemotherapy regimens (3GR) improve survival over second generation regimens (2GR) in stage IIIB/IV non-small cell lung cancer (NSCLC): a meta-analysis of the published literature (Abstract);Baggstrom;Proc Am Soc Clin Oncol,2002

2. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer;Noda;N Engl J Med,2002

3. A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer;Fukuoka;J Clin Oncol,1992

4. CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer;Masuda;J Clin Oncol,1992

5. Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer;Murphy;J Natl Cancer Inst,1993

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative Investigation of Irinotecan Metabolism, Transport, and Gut Microbiome Activation;Drug Metabolism and Disposition;2021-06-01

2. Population pharmacokinetic model of irinotecan and its four main metabolites in patients treated with FOLFIRI or FOLFIRINOX regimen;Cancer Chemotherapy and Pharmacology;2021-04-28

3. Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics;Clinical Pharmacokinetics;2018-03-08

4. Phase I trial of weekly irinotecan and paclitaxel combined with carboplatin in patients with advanced cancer: a Hellenic Cooperative Oncology Group Study;Anti-Cancer Drugs;2010-09